Search
Displaying results 501 - 510 of 10000 in total
Raloxifene
go.drugbank.com/drugs/DB00481ApprovedInvestigationalHowever, it has a negligible effect on altering the development and progression of breast cancer itself. … [A4979,T28] Exhibiting tissue-specific effects distinct from [estradiol], raloxifene is the first of the benzothiophene group of antiestrogens to be labelled a SERM.
Categories: P-glycoprotein substrates, Cytochrome P-450 CYP2B6 InhibitorsSynonyms: (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone2''-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin
go.drugbank.com/drugs/DB04717ExperimentalSynonyms: 2''-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycinN-2-Thiophen-2-Yl-Acetamide Boronic Acid
go.drugbank.com/drugs/DB02094ExperimentalSynonyms: N-2-Thiophen-2-Yl-Acetamide Boronic Acid2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine
go.drugbank.com/drugs/DB02287ExperimentalSynonyms: [2-(2-Hydroxyphenyl)-1H-benzimidazol-5-yl](imino)methanaminium2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine
go.drugbank.com/drugs/DB02463ExperimentalSynonyms: 2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID
go.drugbank.com/drugs/DB06952ExperimentalSynonyms: (2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID2-Amino-4-(2-Amino-Ethoxy)-Butyric Acid
go.drugbank.com/drugs/DB02971ExperimentalSynonyms: 2-Amino-4-(2-Amino-Ethoxy)-Butyric AcidEstramustine
go.drugbank.com/drugs/DB01196ApprovedWithdrawnA nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties.
Categories: Cytochrome P-450 Substrates, P-glycoprotein inhibitorsSynonyms: Estradiol 3-(N,N-bis(2-chloroethyl)carbamate), 17β-Estradiol 3-(bis(2-chloroethyl)carbamate)Ferrous fumarate
go.drugbank.com/drugs/DB14491ApprovedInvestigationalUsed in treatment of iron deficiency anemia.
Mixtures: Vitamin C 202,8 mg/0,8 mg/100 mg - Hartkapseln, Stom #2Synonyms: Iron(2+) fumarateBelinostat
go.drugbank.com/drugs/DB05015ApprovedInvestigationalIntravenous administration of the agent is available as Beleodaq as monotherapy and the dosing regimen involves a 21-day cycle. … Belinostat is a novel agent that inhibits the enzyme histone deacetylase (HDAC) with a sulfonamide-hydroxamide structure.
Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic IndexSynonyms: (2E)-N-HYDROXY-3-(3-(PHENYLSULFAMOYL)PHENYL)PROP-2-ENAMIDE, N-Hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide